In the BioHarmony Drug Report Database

"Preview" Icon

Miconazole

Monistat, Oravig, Vfend (miconazole) is a small molecule pharmaceutical. Miconazole was first approved as Monistat on 1982-01-01. It is used to treat aspergillosis, cutaneous candidiasis, mycoses, tinea pedis, and tinea versicolor amongst others in the USA. It has been approved in Europe to treat aspergillosis, bacterial infections and mycoses, candidiasis, and mycoses. It is known to target transient receptor potential cation channel subfamily M member 2 and transient receptor potential cation channel subfamily V member 5. Miconazole nitrate’s patent is valid until 2022-09-11 (FDA).

 

Trade Name

 

Vfend
 

Common Name

 

miconazole
 

ChEMBL ID

 

CHEMBL91
 

Indication

 

aspergillosis, bacterial infections and mycoses, candidiasis, cutaneous candidiasis, mycoses, tinea pedis, tinea versicolor, vulvovaginal candidiasis
 

Drug Class

 

Systemic antifungals (miconazole type)

Image (chem structure or protein)

Miconazole structure rendering